Ashiq Mubarack

Stock Analyst at Citigroup

(0.87)

# 3,806

Out of 4,944 analysts

3

Total ratings

66.67%

Success rate

-19.45%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$150 → $125	$6.33	+1,874.72%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.36	+138.10%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $150 → $125

Current: $6.33

Upside: +1,874.72%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.36

Upside: +138.10%